Collectively, based on the above in vivo and in vitro experiments, we can conclude that in the chronic liver fibrosis model, the nontoxic ligand YH439 activates AHR to promote ferroptosis of mHSCs, but does not cause ferroptosis in healthy hepatocytes, thus alleviating liver fibrosis. Here, AHR is linked to Hepatic fibrosis.